FA
TEVA icon

FDx Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

FDx Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Sell
15,208
-428
-3% -$14.3K 0.16% 96
2026
Q1 		$471K Buy
+15,636
New +$503K 0.15% 99
2018
Q2 		– Sell
-36,198
Closed -$619K – 1084
2018
Q1 		$619K Sell
36,198
-2,667
-7% -$52.1K 0.02% 666
2017
Q4 		$736K Sell
38,865
-50,920
-57% -$766K 0.02% 649
2017
Q3 		$1.58M Buy
89,785
+13,658
+18% +$307K 0.04% 393
2017
Q2 		$2.53M Buy
76,127
+26,472
+53% +$819K 0.07% 235
2017
Q1 		$1.59M Buy
49,655
+5,987
+14% +$204K 0.05% 362
2016
Q4 		$1.58M Buy
43,668
+18,075
+71% +$722K 0.05% 355
2016
Q3 		$1.18M Sell
25,593
-8,247
-24% -$430K 0.05% 341
2016
Q2 		$1.7M Buy
33,840
+18
+0.1% +$958 0.08% 232
2016
Q1 		$1.81M Buy
33,822
+13,811
+69% +$810K 0.08% 214
2015
Q4 		$1.31M Buy
20,011
+10,064
+101% +$622K 0.06% 278
2015
Q3 		$562K Sell
9,947
-4,165
-30% -$270K 0.05% 414
2015
Q2 		$834K Sell
14,112
-1,088
-7% -$67.1K 0.04% 388
2015
Q1 		$946K Sell
15,200
-961
-6% -$55.9K 0.02% 624
2014
Q4 		$929K Buy
16,161
+6,225
+63% +$347K 0.06% 329
2014
Q3 		$534K Buy
+9,936
New +$526K 0.03% 560
2013
Q4 		– Sell
-42,101
Closed -$1.59M – 668
2013
Q3 		$1.59M Sell
42,101
-1,461
-3% -$57K 0.19% 117
2013
Q2 		$1.71M Buy
+43,562
New +$1.7M 0.23% 105

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

FDx Advisors's TEVA Position: Q2 2026 in Review

FDx Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 2.7% in Q2 2026, selling an estimated $14.3K and leaving 15,208 shares worth $515K. The position accounts for 0.16% of the portfolio, ranked #96.

FDx Advisors first reported a position in TEVA in Q2 2013 and has held it in 19 quarters since. The position peaked at $2.53M in Q2 2017. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • FDx Advisors held 15,208 shares of Teva Pharmaceuticals worth $515K as of Q2 2026.
  • FDx Advisors sold 428 Teva Pharmaceuticals shares in Q2 2026, an estimated $14.3K.
  • Teva Pharmaceuticals made up 0.16% of FDx Advisors's portfolio in Q2 2026, its #96 holding.
  • FDx Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
  • FDx Advisors's Teva Pharmaceuticals position peaked at $2.53M in Q2 2017.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on FDx Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.